Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM37C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $80,206
Award facts
- Contract value 100% obligated
- $80,205.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $80,205.59 to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent pens on January 9, 2026, with completion targeted for January 12, 2026. This firm fixed-price, competitively awarded delivery order (with no set-aside designation) will be performed at the contractor's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication used to treat various allergic and inflammatory conditions, including atopic dermatitis and eosinophilic esophagitis. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting military healthcare systems and programs administered by the Defense Health Agency. The company's extensive portfolio of delivery orders with the DLA demonstrates its capability to supply a diverse range of brand-name and generic medications across multiple therapeutic domains on a competitive basis. This specific Dupixent delivery order reflects the ongoing pharmaceutical support requirements of military treatment facilities and federal healthcare programs that rely on AmerisourceBergen's nationwide distribution infrastructure and established supply chain capabilities.
Quick answers
Who was awarded contract SPE2DR26FM37C?
SPE2DR26FM37C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FM37C worth?
The government has obligated $80,206 on SPE2DR26FM37C.
Is contract SPE2DR26FM37C an order under another contract?
Yes. SPE2DR26FM37C is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM37C competed?
The extent of competition for SPE2DR26FM37C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award